NWPF

News ArchivesRead News

Imaging Biomarker Proposed for Parkinson’s Disease

Thursday July 10, 2014

Eleanor McDermid

Medwire News - Reduced off-medication connectivity in the basal ganglia network (BGN) separates patients with early Parkinson’s disease (PD) from healthy controls with high accuracy, preliminary findings suggest.

Furthermore, the differences in BGN connectivity disappeared when the PD patients in the study were taking dopaminergic medication.

“This finding suggests that reduced connectivity in the BGN is a functional rather than structural phenomenon and is related to PD-specific dopamine-dependent processes”, write senior study authors Michele Hu and Clare Mackay, from the University of Oxford in the UK, and team in Neurology.

The researchers created a BGN template using an observer-independent technique on data from 80 healthy elderly controls who underwent resting-state functional magnetic resonance imaging (RS-fMRI). They then created BGN connectivity maps of 19 PD patients and 19 age- and gender-matched healthy controls.

The PD patients had been diagnosed within the past 3 years and were taking medication. When scanned 12 to 17 hours after medication withdrawal these patients had significantly reduced connectivity relative to controls in nine clusters across the BGN: the putamen and caudate bilaterally, midbrain, superior temporal gyrus bilaterally, dorsolateral prefrontal cortex bilaterally, medial prefrontal cortex, and precuneus.

BGN connectivity significantly increased in the patients when they were scanned on medication, abolishing the differences relative to the controls.

The average connectivity parameter estimates (PE) value for the significantly different clusters was 1.04 in the PD patients versus 7.59 in controls. In a post-hoc analysis, a PE value of 3.88 distinguished between patients and controls with 100% sensitivity and 89.5% specificity.

The researchers applied this cutoff to a validation cohort of 13 PD patients, including five drug-naïve patients, and it classified these individuals with 85% accuracy (two were misclassified). It correctly classified four of the five drug-naïve patients, which the team says increases the “robustness of the finding and speaks against it being a simple effect of short-term medication withdrawal.”

BGN connectivity was not associated with clinical measures of PD symptom severity, which the team says may mean that it “is a trait marker of disease, reflecting a constitutional fault of the network and not the resulting clinical symptoms.”

In an editorial accompanying the study, Nicolaas Bohnen (University of Michigan, Ann Arbor, USA) and WR Wayne Martin (University of Alberta, Edmonton, Canada) say: “Although clinical translation of RS-fMRI to real-world neurology practice will need to clear many more hurdles, this proof-of-concept study offers great promise for the future.

“It demonstrates the potential for a functional and dopaminergic medication-responsive MRI technique to characterize disease-specific brain networks that can be quantitatively expressed and provide a reader-independent diagnosis.”

McDermid, Eleanor. (10 July 2014). Medwire News. Imaging Biomarker Proposed for Parkinson’s Disease. http://www.medwirenews.com/454/105718/Parkinsons_disease/Imaging_biomarker_proposed_for_Parkinsons_disease.html

Recent News

Nov 17 - 'Moving Day' participant is not letting young-onset Parkinson's disease stop him
Nov 17 - Focused ultrasound shows promise for treating Parkinson's tremor
Nov 17 - New research to target air pollution as a potential trigger for Parkinson’s
Nov 17 - This device will let you feel what it's like to suffer from Parkinson's
Nov 10 - How does Parkinson's disease influence depression?
Nov 10 - House votes to repeal ObamaCare's Medicare cost-cutting board
Nov 10 - Microsoft shows off watch that quiets Parkinson's tremors
Nov 3 - Utah group battling Parkinson's disease with boxing
Nov 3 - UVA-LED STUDY EXAMINES POTENTIAL OF SOUND WAVES TO MANAGE PARKINSON’S DISEASE
Oct 27 - Herbicide's link to Parkinson's disease
Oct 27 - NTU Singapore, KAIST scientists discover new mechanism that causes Parkinsonian symptoms
Oct 27 - 70,000 Washingtonians face higher insurance costs after Trump order, officials say
Oct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 18 - Fighting Parkinson's disease through dance
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests